|
The objectives of ERFA Canada are to:
 | Market (through partnerships and/or through our own business
organisations), first in Canada and later in NAFTA's geographical area,
pharmaceutical products belonging to ERFA SA (and therefore to obtain regulatory
approvals in Canada and other NAFTA countries).
|
|
Acquire
(by purchasing or in-licensing) from internationally recognized companies
products patented in Canada (trade marks and/or generics) in order
to market them in Canada and/or Europe, focusing on pharmaceutical
products that are safe values having a proven contribution in family
healthcare.
|
| Obtain a minority participation in a Canadian manufacturing unit in order
to acquire manufacturing, packaging and distribution capabilities for the
ERFA product portofolio.
|
| At the appropriate time, take full property of a pharmaceutical
manufacturing and packaging site (otherwise due to disappear, following the
many mergers of worldwide public pharmaceutical companies).
|
| In Quebec, coordinate research projects that focus on biotechnology,
molecular pharmacodynamics, biopolymers and niche pathologies.
|
|
Provide
to sister corporations (including EuroSourcing
and NaftaSourcing) and to our business relations, in NAFTA countries
as well as in the European Community, IT support and multilingual
programming services in consulting, computer management (LAN, WAN,
VPN, INTRA-, EXTRA-, INTERNET) together with forecasting software
support (FUTURCAST), through
computer scientists recruited in Canada and with the help of a Montreal-based
server. |
We will complete these missions by establishing long-term partnerships with
our suppliers and customers, by ensuring respect and appropriate development of
all our employees and contributors, and by being dedicated corporate and loyal
citizens.
|
